Oxidative degradation products of atorvastatin calcium

Details Oxidative degradation products of atorvastatin calcium Oxidative degradation products of atorvastatin calcium

2005-07-15

2011-10-25

Loewe, Sun Jae (Department: 1622)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S423000

Reexamination Certificate

active

08044086

ABSTRACT:
The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.

REFERENCES:
patent: 5003080 (1991-03-01), Butler et al.
patent: 5097045 (1992-03-01), Butler et al.
patent: 5103024 (1992-04-01), Millar et al.
patent: 5124482 (1992-06-01), Butler et al.
patent: 5149837 (1992-09-01), Butler et al.
patent: 5155251 (1992-10-01), Butler et al.
patent: 5216174 (1993-06-01), Butler et al.
patent: 5245047 (1993-09-01), Butler et al.
patent: 5248793 (1993-09-01), Millar et al.
patent: 5273995 (1993-12-01), Roth et al.
patent: 5280126 (1994-01-01), Butler et al.
patent: 5342952 (1994-08-01), Butler et al.
patent: 5397792 (1995-03-01), Butler et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 2003/0114497 (2003-06-01), Alani et al.
patent: 21302 (2004-04-01), None
patent: WO 01/45677 (2000-12-01), None
patent: 0132161 (2001-05-01), None
patent: 0137876 (2001-05-01), None
patent: 0158443 (2001-08-01), None
patent: WO03/011826 (2003-02-01), None
patent: WO03/018547 (2003-03-01), None
Kerkhof; caplus an 2006:982493.
Sebek et al., caplus an 2005:120702.
Waterman, et al, 2002. “Stabilization of Pharmaceuticals to Oxidative Degradation” Pharmaceutical Development and Technology 7(1): 1-32.
Byrn, et al. Solid State Chemistry of Drugs, 2nd Edition. West Lafayette: SSCI, 1999. pp. 315-348.
Hurley: Photodecomposition of CI-981, an HMG-CoA reductase inhibitor Tetrehedron, Elsevier Science Publishers, Amsterdam, NL vol. 49, No. 10 Mar. 5, 1993, pp. 1979-1984, XP002363647 ISSN: 0040-4020.
International search report, 2004.

Affiliated with

Also associated with

Rating

Oxidative degradation products of atorvastatin calcium does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxidative degradation products of atorvastatin calcium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidative degradation products of atorvastatin calcium will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4285635